Literature DB >> 12757978

Human epithelial cell immortalization as a step in carcinogenesis.

Martha R Stampfer1, Paul Yaswen.   

Abstract

Human epithelial cells encounter two senescence barriers that enforce a limited proliferative potential. A first barrier is mediated by the retinoblastoma protein, and can be overcome by multiple types of errors, many of which are observed in human cancers. A second, extremely stringent telomere-dependent barrier, is a consequence of repression of telomerase activity. Although relieved by ectopic hTERT expression, the nature of the errors required to overcome this latter barrier during in vivo carcinogenesis have not yet been defined. Attainment of immortality and telomerase reactivation are crucial to human carcinoma development; the derangements responsible for attainment of immortality may be rate-limiting and permissive for further progression to malignancy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12757978     DOI: 10.1016/s0304-3835(02)00707-3

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  27 in total

1.  Co-regulation of p16INK4A and migratory genes in culture conditions that lead to premature senescence in human keratinocytes.

Authors:  Benjamin W Darbro; Galen B Schneider; Aloysius J Klingelhutz
Journal:  J Invest Dermatol       Date:  2005-09       Impact factor: 8.551

2.  Human diploid fibroblast cells in senescence; cycling through polyploidy to mitotic cells.

Authors:  Kirsten H Walen
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Jul-Aug       Impact factor: 2.416

3.  TRIM24 links glucose metabolism with transformation of human mammary epithelial cells.

Authors:  T N Pathiraja; K N Thakkar; S Jiang; S Stratton; Z Liu; M Gagea; X Shi; P K Shah; L Phan; M-H Lee; J Andersen; M Stampfer; M C Barton
Journal:  Oncogene       Date:  2014-07-28       Impact factor: 9.867

4.  Oncogenes induce senescence with incomplete growth arrest and suppress the DNA damage response in immortalized cells.

Authors:  Michael Y Sherman; Le Meng; Martha Stampfer; Vladimir L Gabai; Julia A Yaglom
Journal:  Aging Cell       Date:  2011-09-16       Impact factor: 9.304

5.  Methylation of the p16(INK4a) promoter region in telomerase immortalized human keratinocytes co-cultured with feeder cells.

Authors:  B W Darbro; K M Lee; N K Nguyen; F E Domann; A J Klingelhutz
Journal:  Oncogene       Date:  2006-06-12       Impact factor: 9.867

6.  Molecular distinctions between stasis and telomere attrition senescence barriers shown by long-term culture of normal human mammary epithelial cells.

Authors:  James C Garbe; Sanchita Bhattacharya; Batul Merchant; Ekaterina Bassett; Karen Swisshelm; Heidi S Feiler; Andrew J Wyrobek; Martha R Stampfer
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

7.  The ability to generate senescent progeny as a mechanism underlying breast cancer cell heterogeneity.

Authors:  Mine Mumcuoglu; Sevgi Bagislar; Haluk Yuzugullu; Hani Alotaibi; Serif Senturk; Pelin Telkoparan; Bala Gur-Dedeoglu; Burcu Cingoz; Betul Bozkurt; Uygar H Tazebay; Isik G Yulug; K Can Akcali; Mehmet Ozturk
Journal:  PLoS One       Date:  2010-06-24       Impact factor: 3.240

8.  Arsenicals produce stable progressive changes in DNA methylation patterns that are linked to malignant transformation of immortalized urothelial cells.

Authors:  Taylor J Jensen; Petr Novak; Shawn M Wnek; A Jay Gandolfi; Bernard W Futscher
Journal:  Toxicol Appl Pharmacol       Date:  2009-08-28       Impact factor: 4.219

9.  Different mutant/wild-type p53 combinations cause a spectrum of increased invasive potential in nonmalignant immortalized human mammary epithelial cells.

Authors:  Damian J Junk; Lukas Vrba; George S Watts; Marc M Oshiro; Jesse D Martinez; Bernard W Futscher
Journal:  Neoplasia       Date:  2008-05       Impact factor: 5.715

10.  p53-dependent integration of telomere and growth factor deprivation signals.

Authors:  Alain Beliveau; Ekaterina Bassett; Alvin T Lo; James Garbe; Miguel A Rubio; Mina J Bissell; Judith Campisi; Paul Yaswen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.